Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 47.77B 7.16B 6.52B 6.01B 5.46B 10.25B 663B 10.77B 73.1B 29.05B 362B 26.85B 26.29B 1,136B P/E 2026 *
37.1x
P/E 2027 * 27.7x
Enterprise Value 43.99B 6.59B 6B 5.53B 5.03B 9.44B 610B 9.92B 67.31B 26.75B 333B 24.72B 24.2B 1,046B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.54x
Free-Float
62.23%
Yield 2026 *
0.97%
Yield 2027 * 1.35%
Manager TitleAgeSince
Chief Executive Officer 70 06/10/1998
Chief Executive Officer 49 18/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 17/07/2011
Chairman 70 06/10/1998
Director/Board Member 65 17/07/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 7.4B
-0.30%-6.68%+29.12%+125.42% 1,204B
+1.25%-5.35%+33.19%+80.42% 643B
+0.94%-2.99%+24.73%+106.93% 501B
-0.60%-2.39%+27.92%+67.00% 378B
+0.69%-9.50%+40.80%+30.23% 327B
+0.41%-4.81%+24.99%+51.91% 285B
+0.81%-3.72%-1.35%+30.72% 270B
-0.15%-6.45%+29.63%+64.18% 237B
-0.06%-0.98%+33.15%+118.99% 207B
Average +0.33%-4.40%+26.91%+75.09% 450B
Weighted average by Cap. +0.34%-4.71%+27.97%+87.45%

Financials

2026 *2027 *
Net sales 8.09B 1.21B 1.1B 1.02B 925M 1.74B 112B 1.82B 12.37B 4.92B 61.27B 4.55B 4.45B 192B 9.83B 1.47B 1.34B 1.24B 1.12B 2.11B 136B 2.22B 15.04B 5.98B 74.45B 5.52B 5.41B 234B
Net income 1.32B 198M 181M 167M 152M 284M 18.38B 299M 2.03B 806M 10.04B 745M 729M 31.51B 1.78B 266M 243M 224M 203M 382M 24.68B 401M 2.72B 1.08B 13.48B 1B 979M 42.3B
Net Debt -3.79B -567M -517M -476M -433M -812M -52.52B -854M -5.79B -2.3B -28.69B -2.13B -2.08B -90.03B -2.84B -426M -388M -357M -325M -610M -39.43B -641M -4.35B -1.73B -21.54B -1.6B -1.56B -67.6B
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Asymchem Laboratories (Tianjin) Co., Ltd.